Trimel Pharmaceuticals Corp. announced that effective January 3, 2013, Bruce D. Brydon has stepped down as the company's Chief Executive Officer. Mr. Brydon, with the unanimous support of the company's board of directors, has announced that Tom Rossi has been appointed to the position of Chief Executive Officer.

Mr. Brydon will remain as Chairman of the board of directors. Mr. Rossi joined the company in August of 2011 as President and was subsequently promoted in March 2012 to include the position of Chief Operating Officer. Most recently, Rossi has held senior positions with Novartis Pharmaceuticals, where he served in a number of senior positions reaching the level of Chief Executive Officer for operating businesses in Belgium and most recently in Canada.